Providence Medical Technology announced CE mark approval for its Dtrax facet system, a novel implant for neck and arm pain that provides indirect decompression of nerve roots and stabilises the treated motion segment.
Dtrax is a minimally invasive approach to cervical spinal decompression that provides distraction of the facet joint increasing neural foraminal volume for nerve root decompression.
The procedure involves an implant being inserted percutaneously under fluoroscopic guidance through a 1cm working channel. Dtrax is anchored in the facet joint and simultaneously distracts and immobilises the joint to relieve pressure on the nerve root. Bone graft may be added to aid with fusion of the facet joints.
Dtrax was developed in collaboration with neurosurgeons and orthopaedic surgeons. The company has already completed enrolment of a clinical study where the safety and efficacy has been shown to be comparable to anterior cervical discectomy and fusion procedures.